Clinical trial

Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)

NCT00917748

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention DOCETAXEL(XRP6976) + MODAFINIL Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Modafinil Normalized identity: modafinilView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo of Modafinil Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-06-01

PhasePHASE3

Conditions

Prostatic Neoplasmsunresolved

Breast Cancerverified · MONDO: breast cancer

Interventions

DOCETAXEL(XRP6976) + MODAFINILDRUG

ModafinilDRUG · verified · RxNorm: modafinil

Placebo of ModafinilDRUG

Sponsors & collaborators

Sanofilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00917748 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.